Madrigal Pharmaceuticals
Jeremy A. Aiss is a seasoned professional in commercial strategy and operations within the pharmaceutical industry, currently serving as Senior Director, Commercial Strategy & Operations at Madrigal Pharmaceuticals. Previously, Jeremy held various positions at Bristol Myers Squibb, including Team Lead for Global Commercialization Analytics and Portfolio Lead for Global Commercial Strategy & Forecasting in Immunology, Pulmonary, and Neuroscience. Jeremy also led the Global Immunology and Fibrosis Pipeline for Commercial Strategy and Forecasting. Prior experience includes roles as Associate Director of US Business Analytics & Insights for Eliquis at Pfizer, Consultant for Life Sciences Strategy at IQVIA, and Senior Consultant for Life Sciences Strategy at Navigant.
This person is not in any teams
Madrigal Pharmaceuticals
4 followers
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.